Clinical trial
Observational Cohort Study of Health-related Quality of Life in Patients Initiating Treatment With Chemotherapy for Metastatic Pancreatic Cancer
NCT02342847 is registered in ClinicalTrials.gov with Celgene as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Observational Cohort Study of Health-related Quality of Life in Patients Initiating Treatment With Chemotherapy for Metastatic Pancreatic Cancer
- Lead sponsor
- Celgene
- Phase
- Observational
- Overall status
- Completed
- Start date
- December 10, 2014
- Completion date
- November 16, 2018
- Enrollment
- 120 (actual)
- Sites
- 12
Conditions
As the registry lists them; a condition with its own page is linked.